steven_bradshaw

MKTXS appoints Dr Steven Bradshaw as director

pharmafile | July 30, 2014 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

Global healthcare strategy firm MKTXS has appointed British medical research expert Dr Steven Bradshaw as its new European director.

Market Access Solutions (MKTXS) provides consulting services on market access, health economics, outcomes research, product pricing and portfolio evaluations to healthcare technology companies.

Dr Bradshaw has over 15 years’ experience in the healthcare industry and has an extensive practical understanding of the real-world issues facing patients, payers, providers and pharma.

Advertisement

Before MKTXS, Dr Bradshaw was Asia-Pacific lead and medical advisor at Evidera. He was formerly senior global market access consultant at United BioSource Corporation.

Dr Bradshaw says: “It’s a great honour to be appointed as the European director for MKTXS. As a former doctor in the NHS for over eight years, I understand how new health technologies can bring benefits to patients; optimal market access is central to the success of the healthcare industry and to patient outcomes.”

In his new role, Dr Bradshaw will be advising pharmaceutical, medical device and biotech firms on strategic global market access, evidence generation to best support health technologies, and other commercial initiatives.

Related Content

No items found
The Gateway to Local Adoption Series

Latest content